Japan Geographic Atrophy Market (2025-2031) | Growth, Trends, Forecast, Value, Segmentation, Companies, Analysis, Competitive Landscape, Size & Revenue, Industry, Share, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Geographic Atrophy Market Revenues & Volume, 2021 & 2031F

3.3 Japan Geographic Atrophy Market - Industry Life Cycle

3.4 Japan Geographic Atrophy Market - Porter's Five Forces

3.5 Japan Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F

3.6 Japan Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.7 Japan Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing aging population in Japan leading to a higher prevalence of geographic atrophy

4.2.2 Increasing awareness and diagnosis rates of geographic atrophy in Japan

4.2.3 Advancements in medical technology and treatment options for geographic atrophy

4.3 Market Restraints

4.3.1 High cost of treatment for geographic atrophy affecting affordability and access

4.3.2 Limited availability of specialized healthcare professionals for managing geographic atrophy cases in Japan

6.1 Japan Geographic Atrophy Market, By Age Group

6.1.1 Overview and Analysis

6.1.2 Japan Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F

6.1.3 Japan Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F

6.1.4 Japan Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F

6.2 Japan Geographic Atrophy Market, By Diagnosis

6.2.1 Overview and Analysis

6.2.2 Japan Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F

6.2.3 Japan Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F

6.2.4 Japan Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F

6.3 Japan Geographic Atrophy Market, By Therapeutic Agents Clinical Phase

6.3.1 Overview and Analysis

6.3.2 Japan Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F

6.3.3 Japan Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F

6.3.4 Japan Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F

7.1 Japan Geographic Atrophy Market Export to Major Countries

7.2 Japan Geographic Atrophy Market Imports from Major Countries

8.1 Number of clinical trials and research studies focused on geographic atrophy treatments

8.2 Rate of adoption of new technologies and treatment modalities for geographic atrophy

8.3 Number of healthcare facilities equipped to diagnose and treat geographic atrophy

9.1 Japan Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F

9.2 Japan Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.3 Japan Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F

10.1 Japan Geographic Atrophy Market Revenue Share, By Companies, 2024

10.2 Japan Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters